Buphenyl

DRUG2 trials

Sponsors

Amgen, University of Pittsburgh

Conditions

Byler DiseaseHealthy

Phase 1

A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)

CompletedNCT00977600

Start: 2005-03-31End: 2005-07-31Updated: 2024-06-20

Unknown Phase

Buphenyl Therapy for Byler's Disease

University of PittsburghByler Disease

Updated: 2013-02-06